An interventional study of Exergame and Robotic in Stroke and Paralysis Arm, sponsored by Hasanuddin University. Recruiting at 2 sites in Indonesia. Per ClinicalTrials.gov, last updated 2024-08-20.
Sponsored by Hasanuddin University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Stroke with a site in Indonesia — 7 open to participants now, 8 under way, none of them phase 3. Stroke · Indonesia.
Among the 13 studies in Stroke with a site in Indonesia, this one is the 5th largest by planned enrollment of the 10 interventional ones that give a count, is one of 3 that started in 2023, is one of 7 with no phase, and was the 9th registered.
8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.
Browse Stroke studies →7 of the 13 studies in Stroke with a site in Indonesia are open now. Recruiting first, the newest first:
Universitas Padjadjaran · Sites in Indonesia
Ages 18+
Kaohsiung Medical University · Sites in Indonesia
Ages 18–90
Universitas Padjadjaran · Sites in Indonesia
Ages 40–65
Universitas Padjadjaran · Sites in Indonesia
Ages 18–59
Universitas Muhammadiyah Surakarta · Sites in Indonesia
Ages 18+
A study can be open while its sites in Indonesia have not opened yet or have stopped. Only those recruiting at a site in Indonesia →
Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 1 · Phase 3 2
First in 2007; this study’s year is marked. 3 started in 2023.
This study's planned enrollment of 48 is close to the median of 48 across 6,049 interventional studies indexed under Stroke.
Median enrollment 44 across the 10 interventional studies, 2,297 across the 3 observational. Of the 4 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
2 of 13 have an industry lead sponsor. The 9 most frequent:
Hasanuddin University is the lead sponsor of 71 studies on the registry; 6 are open to participants now.
Hasanuddin University has 2 studies filed under Stroke — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 13 studies in Stroke with a site in Indonesia, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
This clinical trial aims to compare the effectiveness of Robotic versus Exergame versus Standard therapy to improve hand function among post-stroke patients. The main questions it aims to answer are:
1, Effectiveness of interventions in functional outcome recovery across time 2. Effectiveness of interventions in affecting Tenascin-C level 3. Clinical outcome difference between all interventions
Participants will be allocated into three groups, either a robotic group, exergame group as the main interventions, and standard rehabilitation group as the active comparator. A serial follow-up will be conducted to assess the selected clinical outcome and differences in outcome
1, Research design This research is an experimental study with a randomized controlled trial research design.
a. Standard Rehabilitation Comprehensive medical management and rehabilitation of disabilities caused by stroke through the neurorehabilitation approach with the aim of optimizing recovery and or modifying existing remaining symptoms so that stroke people are able to carry out functional activities independently, can adapt to the environment and achieve quality life
b. Exergame Physical exercise of the entire body carried out through active video games that require gross motor skills, visual-spatial coordination, balance, and energy expenditure that are proportional to the intensity of moderate physical activity
c. Robotic Therapy Mirror therapy intervention uses the help of robot exoskeletal to move the sick side. A set of mirror therapy exercises, using Syrebo robotics, using 1 set of Activity Daily Living (ADL) training during therapy, and using a mirror that will reflect a healthy side shadow.
Level of Tenascin-C in blood serum before and after
a. type of stroke determined by radiology imaging b. phase of stroke (acute, sub-acute or chronic) c. cognitive ability measured using mini-mental state examination (MMSE) d. Spasticity measured by the Modified Ashworth Scale (MAS)
a. The data collected is primary data obtained in accordance with the inclusion criteria.
b. Samples who are willing to become research subjects will undergo interviews, physical examinations, FMA-UE-Hand Motor Domain, handgrip and NHPT examinations. The interview questionnaire in this study will contain a list of patient identities including name, age, marital status, address, educational history, employment history, history of stroke, cognitive examination (MMSE), and self-reported visual ability.
Tenascin-C To perform an ELISA for Tenascin-C, the procedure involves preparing samples and standards according to the kit instructions. The samples and standards are added to wells pre-coated with Tenascin-C-specific antibodies and incubated to facilitate binding. Following incubation, the wells are washed to remove any unbound substances. A detection antibody, conjugated with an enzyme, is then added and incubated. After additional washing, a substrate solution is introduced, causing a color change proportional to the amount of Tenascin-C present. The reaction is stopped with an acid solution, and the optical density is measured using a plate reader. The Tenascin-C concentration in the samples is determined by comparing the optical density readings to a standard curve. Typically, Tenascin-C levels are reported in pg/mL, and the assay range and sensitivity depend on the specific kit used. Accurate interpretation requires comparing the sample values to the standard curve to assess Tenascin-C expression levels, which can provide insights into the biological or pathological state being investigated.
This clinical trial aims to compare the effectiveness of Robotic Therapy, Exergame Therapy, and Standard Therapy in improving hand function among post-stroke patients. Assuming a standard deviation of 26.75, an expected mean difference of 18.72, and a dropout rate of 30%, the sample size is calculated to be 16 participants per group. This calculation is based on a 95% confidence level (Zα = 1.96) and 80% power (Zβ = 0.84) across the three arms.
the data will be analyzed using Analysis of Variance/ ANOVA assuming no difference in baseline characteristic. Next, the relationship between continuous values will be assessed using the Pearson correlation test (normally distributed data) or the Spearman test (data not normally distributed) to determine how big the correlation is between these variables.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Dropout Criteria
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
MMSE and MoCA
Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The conventional exercise therapy group will be given diathermic, electricity modality, hydrotherapy, and therapeutic exercises in the form of muscle stretching, strengthening exercises, transfer exercises, walking exercises, and hand function exercises for 3 times a week within 6 weeks.
Procedure: Conventional
Conventional therapy coupled with virtual reality Exergame exercises on the hands for 3 times a week a time 6 weeks
Procedure: Exergame
conventional therapy coupled with robotic therapy exercises on the hands for 3 times a week a time of 6 weeks
Procedure: Robotic
Hand Training assisted with Virtual-Reality
Hand Training assisted with Robotic Syrebo
Hand Training with Physical Therapist
Fugl-Meyer Assessment Upper Extremity (FMA-EU) Score
a motoric assessment with each score range from 0-2 with a total score range from 0-66. Higher score indicates better and free movement
Time frame: changes of FMA-UE score from pre-intervention to six weeks after intervention
Nine Hole Peg Test Value
an assessment for finger dexterity and coordination where the time of the subject to accomplish task will be recorded. Average healthy adult male completed the NHPT in 19.0 seconds (SD 3.2) with the right hand, and in 20.6 seconds (SD 3.9) with the left hand. For healthy adult women, the NHPT was completed in 17.9 seconds (SD 2.8) and 19.6 seconds (SD 3.4) with the right and left hands, respectively.
Time frame: changes of NHPT values from pre-intervention to six weeks after intervention
Handgrip Dynamometer value
The handgrip dynamometer measures hand strength, with a typical range of 0 to 100 kg (0 to 220 lb). For men, normal handgrip strength usually falls between 30-60 kg (66-132 lb), while for women it ranges from 20-40 kg (44-88 lb).
Time frame: changes of handgrip values from pre-intervention to six weeks after intervention
Tenascin-C value
The normal range of Tenascin-C levels in healthy individuals typically falls between 50 to 200 ng/mL.
Time frame: changes of Tenascin-C value from pre-intervention to six weeks after intervention
Plan to share: No — No To protect the confidentiality, should the data need to share, any de-identified data will be shared for peer-review
No publications or documents are linked to this record.
Started Oct 2023 (actual). Primary completion is estimated for Dec 2024, 14 months after the start.
Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 14 months is below that.
Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hasanuddin University